TransCelerate BioPharma

TransCelerate BioPharma is a nonprofit consortium of 20 of the world’s leading global biopharmaceutical companies. Through collaboration across the R&D ecosystem, TransCelerate aims to drive innovation, simplify clinical trials and help bring new treatments to patients faster, safer and more efficiently.

Content by TransCelerate BioPharma

A senior gentleman wearing a blue shirt sits beside his doctor in a white lab coat as they review test results on a tablet together in a doctor’s office.

| 7 min read

byBree FosterandTransCelerate BioPharma

Redesigning clinical trials using artificial intelligence

Artificial intelligence is prompting a fundamental rethink of clinical trial design and execution, with the potential to reduce patient burden, improve data quality, and accelerate development timelines.

Industry Perspectives

Page 1 of 1 - 1 Total Items

Sponsored

Close-up illustration of clustered, irregularly shaped 3D cell structures resembling organoids, displayed in a blue-toned background.

Automating the counting of 3D cell cultures

Machine learning-powered image analysis makes it possible to automatically and reliably quantify complex 3D cell structures.

Webinars

Illustration of a glowing human brain with interconnected neural networks and bright data points, set against a dark, digital background.

Imaging neural activity in action

Take a closer look at modern techniques that reveal when, where, and how neurons communicate in real time.

Infographics

Gloved hand holding a petri dish containing red liquid culture medium against a light blue background.

Building complex in vitro models to support new approach methodologies

As global regulations shift toward animal-free testing, how can researchers develop more biologically relevant in vitro models to advance drug discovery?

Webinars

TransCelerate BioPharma

Content by TransCelerate BioPharma

Redesigning clinical trials using artificial intelligence

Subscribe to our eNewsletters

Sponsored

June 2025